The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
An anti-infective peptide that selectively modulates the innate immune response
Abstract
We show that an innate defense-regulator peptide (IDR-1) was protective in mouse models of infection with important Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus and Salmonella enterica serovar Typhimurium. When given from 48 h before to 6 h after infection, the peptide was effective by both local and systemic administration. Because protection by IDR-1 was prevented by in vivo depletion of monocytes and macrophages, but not neutrophils or B- and T-lymphocytes, we conclude that monocytes and macrophages are key effector cells. IDR-1 was not directly antimicrobial: gene and protein expression analysis in human and mouse monocytes and macrophages indicated that IDR-1, acting through mitogen-activated protein kinase and other signaling pathways, enhanced the levels of monocyte chemokines while reducing pro-inflammatory cytokine responses. To our knowledge, an innate defense regulator that counters infection by selective modulation of innate immunity without obvious toxicities has not been reported previously.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The reaction of neutrophils and macrophages during infection triggers the production of innate defence regulatory peptide 1 IDR1, with similar activity to defensins or cathelicidins [223].”
From Superoxide Anion Chemistry—Its Role at the Core of the Innate Immunity (2023) · cites this paper as [223]
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Trends in antimicrobial drug development: Implications for the future
Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/420937 · Cited by 867
Alarmins: chemotactic activators of immune responses
Oppenheim, J. J., & Yang, D. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.06.002 · Cited by 780
NLRs join TLRs as innate sensors of pathogens
Martinon, F., & Tschopp, J. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.06.004 · Cited by 673
Toll-Like Receptors: Linking Innate and Adaptive Immunity
Pasare, C., & Medzhitov, R. M. (2005) · Advances in experimental medicine and biology · doi:10.1007/0-387-24180-9_2 · Cited by 666
How Toll-like receptors signal: what we know and what we don’t know
O'Neill, L. A. J. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.012 · Cited by 614
Mookherjee, N., Brown, K. L., Bowdish, D. M. E., Doria, S., Falsafi, R., Hokamp, K., Roche, F. M., Mu, R., Doho, G., Pistolic, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2455 · Cited by 562
Self-citationInnate immune responses to infection
Tosi, M. F. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.05.036 · Cited by 387
Impact of LL-37 on anti-infective immunity
Bowdish, D. M. E., Davidson, D. J., Lau, Y. E., Lee, K. C. L., Scott, M. G., & Hancock, R. E. W. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0704380 · Cited by 382
Self-citationCavaillon, J., Adib‐Conquy, M., Fitting, C., Adrie, C., & Payen, D. M. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310015935 · Cited by 336
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- National Research Council Treating Infectious Diseases in a Microbial World: Report of Two Workshops. Washington, D.C.: The National Academies Press, (2005).
Cited by
Sorted by citations
Antimicrobial host defence peptides: functions and clinical potential
Mookherjee, N., Anderson, M. A., Haagsman, H. P., & Davidson, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0058-8 · Cited by 1,502
Self-citationKumar, P., Kizhakkedathu, J. N., & Straus, S. K. (2018) · Biomolecules · doi:10.3390/biom8010004 · Cited by 1,233
Phagocyte partnership during the onset and resolution of inflammation
Soehnlein, O., & Lindbom, L. (2010) · Nature Reviews Immunology · doi:10.1038/nri2779 · Cited by 1,054
The immunology of host defence peptides: beyond antimicrobial activity
Hancock, R. E. W., Haney, E. F., & Gill, E. E. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.29 · Cited by 967
Self-citationAlternatives to antibiotics—a pipeline portfolio review
Czaplewski, L. G., Bax, R. P., Clokie, M. R. J., Dawson, M., Fairhead, H., Fischetti, V. A., Foster, S. J., Gilmore, B., Hancock, R. E. W., Harper, D. J., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00466-1 · Cited by 880
Self-citationRaphel, J., Holodniy, M., Goodman, S. B., & Heilshorn, S. C. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.016 · Cited by 678
The Roles of Antimicrobial Peptides in Innate Host Defense
Diamond, G., Beckloff, N., Weinberg, A., & Kisich, K. O. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682325 · Cited by 679
Multifunctional cationic host defence peptides and their clinical applications
Yeung, A. T. Y., Gellatly, S. L., & Hancock, R. E. W. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0710-x · Cited by 613
Self-citationImmune modulation by multifaceted cationic host defense (antimicrobial) peptides
Hilchie, A. L., Wuerth, K. C., & Hancock, R. E. W. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1393 · Cited by 618
Self-citationBiomaterial-based antimicrobial therapies for the treatment of bacterial infections
Kalelkar, P. P., Riddick, M., & Garcı́a, A. J. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00362-4 · Cited by 558
Modulating immunity as a therapy for bacterial infections
Hancock, R. E. W., Nijnik, A., & Philpott, D. J. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2745 · Cited by 558
Self-citationHost defense peptides: front-line immunomodulators
Mansour, S., Pena, O. M., & Hancock, R. E. W. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.07.004 · Cited by 493
Self-citationAntimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds
Pfalzgraff, A., Brandenburg, K., & Weindl, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00281 · Cited by 503
Neutrophils: Cinderella of innate immune system
Kumar, V., & Sharma, A. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.08.012 · Cited by 455
Antibiotics in the clinical pipeline in 2013
Butler, M. S., Blaskovich, M. A. T., & Cooper, M. A. (2013) · The Journal of Antibiotics · doi:10.1038/ja.2013.86 · Cited by 436
Jaynes, J. M., Sable, R. V., Ronzetti, M. H., Bautista, W., Knotts, Z., Abisoye-Ogunniyan, A., Li, D., Calvo, R., Dashnyam, M., Singh, A., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax6337 · Cited by 424
Reassessing the Host Defense Peptide Landscape
Haney, E. F., Straus, S. K., & Hancock, R. E. W. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00043 · Cited by 376
Self-citationCherkasov, A. R., Hilpert, K., Jenssen, H., Fjell, C. D., Waldbrook, M., Mullaly, S. C., Volkmer, R., & Hancock, R. E. W. (2008) · ACS Chemical Biology · doi:10.1021/cb800240j · Cited by 367
Self-citationSuperoxide Anion Chemistry—Its Role at the Core of the Innate Immunity
Andrés, C. M. C., Pérez de la Lastra, J. M., Andrés Juan, C., Plou, F. J., & Pérez-Lebeña, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031841 · Cited by 342
Anionic Antimicrobial Peptides from Eukaryotic Organisms
Harris, F., Dennison, S. R., & Phoenix, D. A. (2009) · Current Protein and Peptide Science · doi:10.2174/138920309789630589 · Cited by 340
De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers
Choi, S., Isaacs, A. K., Clements, D. J., Liu, D., Kim, H., Scott, R. W., Winkler, J. D., & DeGrado, W. F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811818106 · Cited by 306
Antimicrobial Peptides: An Introduction
Haney, E. F., Mansour, S., & Hancock, R. E. W. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6737-7_1 · Cited by 312
Self-citationMechanisms underlying neutrophil-mediated monocyte recruitment
Soehnlein, O., Lindbom, L., & Weber, C. (2009) · Blood · doi:10.1182/blood-2009-06-221630 · Cited by 312
Peptide design for antimicrobial and immunomodulatory applications
Haney, E. F., & Hancock, R. E. W. (2013) · Biopolymers · doi:10.1002/bip.22250 · Cited by 297
Self-citationThe roles of cathelicidin LL-37 in immune defences and novel clinical applications
Nijnik, A., & Hancock, R. E. W. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32831ac517 · Cited by 290
Self-citationCombating Implant Infections: Shifting Focus from Bacteria to Host
Yavari, S. A., Castenmiller, S. M., van Strijp, J. A. G., & Croes, M. (2020) · Advanced Materials · doi:10.1002/adma.202002962 · Cited by 258
Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics
Sang, Y., & Blecha, F. (2008) · Animal Health Research Reviews · doi:10.1017/s1466252308001497 · Cited by 260
Cationic Host Defence Peptides: Multifaceted Role in Immune Modulation and Inflammation
Choi, K.-Y. G., Chow, L. N. Y., & Mookherjee, N. (2012) · Journal of Innate Immunity · doi:10.1159/000336630 · Cited by 241
Self-citationNijnik, A., Madera, L., Ma, S., Waldbrook, M., Elliott, M. R., Easton, D. M., Mayer, M. L., Mullaly, S. C., Kindrachuk, J., Jenssen, H., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901813 · Cited by 222
Self-citationPotential of immunomodulatory host defense peptides as novel anti-infectives
Easton, D. M., Nijnik, A., Mayer, M. L., & Hancock, R. E. W. (2009) · Trends in biotechnology · doi:10.1016/j.tibtech.2009.07.004 · Cited by 218
Self-citationSynthetic antibiofilm peptides
de la Fuente‐Núñez, C., Cardoso, M. H. E. S., Cândido, E. D. S., Franco, O. L., & Hancock, R. E. W. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.12.015 · Cited by 215
Self-citationAuvynet, C., & Rosenstein, Y. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07360.x · Cited by 223
Mansour, S., de la Fuente‐Núñez, C., & Hancock, R. E. W. (2014) · Journal of Peptide Science · doi:10.1002/psc.2708 · Cited by 208
Self-citationGene-specific control of the TLR-induced inflammatory response
Foster, S. L., & Medzhitov, R. M. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.08.015 · Cited by 213
Antimicrobial peptides´ immune modulation role in intracellular bacterial infection
Duarte-Mata, D. I., & Salinas-Carmona, M. C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1119574 · Cited by 200
Fighting bacterial infections—Future treatment options
Fernebro, J. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.02.001 · Cited by 197
Nizet, V. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.06.005 · Cited by 199
Therapeutic Potential of Host Defense Peptides in Antibiotic-resistant Infections
Afacan, N. J., Yeung, A. T. Y., Pena, O. M., & Hancock, R. E. W. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799277617 · Cited by 192
Self-citationQiu, H., Si, Z., Luo, Y. H., Feng, P., Wu, X., Hou, W., Zhu, Y., Chan‐Park, M. B. E., Xu, L., & Huang, D. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00910 · Cited by 190
Neutrophil granule proteins tune monocytic cell function
Soehnlein, O., Weber, C., & Lindbom, L. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.06.006 · Cited by 180
Biomolecule-functionalized polymer brushes
Jiang, H., & Xu, F. (2013) · Chemical Society Reviews · doi:10.1039/c2cs35453e · Cited by 173
Structural Studies of a Peptide with Immune Modulating and Direct Antimicrobial Activity
Wieczorek, M., Jenssen, H., Kindrachuk, J., Scott, W. R. P., Elliott, M. R., Hilpert, K., Cheng, J., Hancock, R. E. W., & Straus, S. K. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.07.007 · Cited by 165
Self-citationNijnik, A., & Hancock, R. E. W. (2009) · Emerging Health Threats Journal · doi:10.3134/ehtj.09.001 · Cited by 173
Self-citationHost Defense Peptide LL-37 Selectively Reduces Proinflammatory Macrophage Responses
Brown, K. L., Poon, G. F. T., Birkenhead, D., Pena, O. M., Falsafi, R., Dahlgren, C., Karlsson, A., Bylund, J., Hancock, R. E. W., & Johnson, P. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002508 · Cited by 163
Self-citationIntracellular Receptor for Human Host Defense Peptide LL-37 in Monocytes
Mookherjee, N., Lippert, D. N. D., Hamill, P., Falsafi, R., Nijnik, A., Kindrachuk, J., Pistolic, J., Gardy, J. L., Miri, P., Naseer, M., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802586 · Cited by 165
Self-citationPerspectives for clinical use of engineered human host defense antimicrobial peptides
Pachón-Ibáñez, M. E., Smani, Y., Pachón, J., & Sánchez-Céspedes, J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux012 · Cited by 159
Bommarius, B., Jenssen, H., Elliott, M. R., Kindrachuk, J., Pasupuleti, M., Gieren, H., Jaeger, K., Hancock, R. E. W., & Kalman, D. (2010) · Peptides · doi:10.1016/j.peptides.2010.08.008 · Cited by 158
Self-citationGao, G., Yu, K., Kindrachuk, J., Brooks, D. E., Hancock, R. E. W., & Kizhakkedathu, J. N. (2011) · Biomacromolecules · doi:10.1021/bm2009697 · Cited by 156
Self-citationInhibitory Effects of Antimicrobial Peptides on Lipopolysaccharide‐Induced Inflammation
Sun, Y., & Shang, D. (2015) · Mediators of Inflammation · doi:10.1155/2015/167572 · Cited by 152
Wu, X., Li, Z., Li, X., Tian, Y., Fan, Y., Yu, C., Zhou, B., Liu, Y., Xiang, R., & Yang, L. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s107195 · Cited by 147
Innate Defense Regulator Peptide 1018 in Wound Healing and Wound Infection
Steinstraesser, L., Hirsch, T., Schulte, M., Kueckelhaus, M., Jacobsen, F., Mersch, E., Stricker, I., Afacan, N. J., Jenssen, H., Hancock, R. E. W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039373 · Cited by 151
Self-citationWei, L., Gao, J., Zhang, S., Wu, S., Xie, Z., Ling, G., Kuang, Y., Yang, Y., Yu, H., & Wang, Y. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.642645 · Cited by 138
Novel peptide therapeutics for treatment of infections
Oyston, P. C. F., Fox, M. A., Richards, S. J., & Clark, G. C. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.011122-0 · Cited by 140
The Road from Host-Defense Peptides to a New Generation of Antimicrobial Drugs
Boto, A., Pérez de la Lastra, J., & González, C. (2018) · Molecules · doi:10.3390/molecules23020311 · Cited by 136
Yang, X., Lee, W., & Zhang, Y. (2011) · Journal of Proteome Research · doi:10.1021/pr200782u · Cited by 132
Avian Antimicrobial Host Defense Peptides: From Biology to Therapeutic Applications
Zhang, G., & Sunkara, L. T. (2014) · Pharmaceuticals · doi:10.3390/ph7030220 · Cited by 131
Future Antibacterial Strategies: From Basic Concepts to Clinical Challenges
Cattoir, V., & Felden, B. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz134 · Cited by 130
Host Defense Peptides: Dual Antimicrobial and Immunomodulatory Action
Drayton, M., Deisinger, J. P., Ludwig, K. C., Raheem, N., Müller, A., Schneider, T., & Straus, S. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011172 · Cited by 133
Rivas-Santiago, B. T., Castañeda‐Delgado, J. E., Rivas-Santiago, C., Waldbrook, M., Gonzalez-Curiel, I. E., León‐Contreras, J. C., Enciso‐Moreno, J. A., del Villar, V., Mendez-Ramos, J., Hancock, R. E. W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059119 · Cited by 124
Self-citationTorrent, M., Navarro, S., Moussaoui, M., Nogués, M. V., & Boix, E. (2008) · Biochemistry · doi:10.1021/bi702065b · Cited by 122
Tan, P., Wu, C., Tang, Q., Wang, T., Zhou, C., Ding, Y., Fu, H., Xu, S., Feng, Y., Zhang, Y., et al. (2023) · Advanced Materials · doi:10.1002/adma.202210766 · Cited by 122
Kindrachuk, J., Jenssen, H., Elliott, M. R., Nijnik, A., Janot, L., Pasupuleti, M., Thorson, L., Ma, S., Easton, D. M., Bains, M., et al. (2012) · Innate Immunity · doi:10.1177/1753425912461456 · Cited by 119
Self-citationThe Human Cathelicidin LL-37 Preferentially Promotes Apoptosis of Infected Airway Epithelium
Barlow, P. G., Beaumont, P. E., Cosseau, C., Mackellar, A., Wilkinson, T. S., Hancock, R. E. W., Haslett, C., Govan, J. R. W., Simpson, A. J., & Davidson, D. J. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0250oc · Cited by 117
Self-citationDong, J., Wang, W., Zhou, W., Zhang, S., Li, M., Li, N., Pan, G., Zhang, X., Bai, J., & Zhu, C. (2022) · Biomaterials Research · doi:10.1186/s40824-022-00326-x · Cited by 117
LL37 and Cationic Peptides Enhance TLR3 Signaling by Viral Double-stranded RNAs
Lai, Y. Y., Adhikarakunnathu, S., Bhardwaj, K., Ranjith-Kumar, C. T., Wen, Y., Jordan, J. L., Wu, L. H., Dragnea, B. G., Mateo, L. S., & Kao, C. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026632 · Cited by 120
The importance of the glycosylation of antimicrobial peptides: natural and synthetic approaches
Bednarska, N. G., Wren, B. W., & Willcocks, S. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.02.001 · Cited by 112
Immunomodulators as adjuvants for vaccines and antimicrobial therapy
Nicholls, E. F., Madera, L., & Hancock, R. E. W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05787.x · Cited by 111
Self-citationSynthetic Mimics of Antimicrobial Peptides with Immunomodulatory Responses
Thaker, H. D., Som, A., Ayaz, F., Lui, D., Pan, W., Scott, R. W., Anguíta, J., & Tew, G. N. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303304j · Cited by 110
Cathelicidins and functional analogues as antisepsis molecules
Mookherjee, N., Rehaume, L. M., & Hancock, R. E. W. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.8.993 · Cited by 109
Self-citationBalamayooran, G., Batra, S., Theivanthiran, B., Cai, S., & Jeyaseelan, S. (2011) · Infection and Immunity · doi:10.1128/iai.00067-11 · Cited by 104
Functions of Cationic Host Defense Peptides in Immunity
Hemshekhar, M., Anaparti, V., & Mookherjee, N. (2016) · Pharmaceuticals · doi:10.3390/ph9030040 · Cited by 103
Self-citationMookherjee, N., Hamill, P., Gardy, J. L., Blimkie, D., Falsafi, R., Chikatamarla, A., Arenillas, D. J., Doria, S., Kollmann, T. R., & Hancock, R. E. W. (2009) · Molecular BioSystems · doi:10.1039/b813787k · Cited by 110
Self-citationIn Vivo, In Vitro, and In Silico Characterization of Peptoids as Antimicrobial Agents
Czyzewski, A. M., Jenssen, H., Fjell, C. D., Waldbrook, M., Chongsiriwatana, N. P., Yuen, E., Hancock, R. E. W., & Barron, A. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0135961 · Cited by 102
Self-citationAntimicrobial Host Defence Peptides: Immunomodulatory Functions and Translational Prospects
van der Does, A. M., Hiemstra, P. S., & Mookherjee, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3588-4_10 · Cited by 105
Self-citationIFN-γ Regulated Chemokine Production Determines the Outcome of Staphylococcus aureus Infection
McLoughlin, R. M., Lee, J. C., Kasper, D. L., & Tzianabos, A. O. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1323 · Cited by 101
Niyonsaba, F., Madera, L., Afacan, N. J., Okumura, K., Ogawa, H., & Hancock, R. E. W. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1012497 · Cited by 100
Self-citationQSAR modeling and computer‐aided design of antimicrobial peptides
Jenssen, H., Fjell, C. D., Cherkasov, A. R., & Hancock, R. E. W. (2007) · Journal of Peptide Science · doi:10.1002/psc.908 · Cited by 100
Self-citationSynthetic Cationic Peptide IDR-1018 Modulates Human Macrophage Differentiation
Pena, O. M., Afacan, N. J., Pistolic, J., Chen, C. C. L., Madera, L., Falsafi, R., Fjell, C. D., & Hancock, R. E. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052449 · Cited by 99
Self-citationThe global need for effective antibiotics—Moving towards concerted action
Cars, O., Hedin, A., & Heddini, A. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.02.006 · Cited by 97
Dhama, K., Saminathan, M., Jacob, S. S., Singh, M. K., Karthik, K., AMARPAL, A., Tiwari, R., Sunkara, L. T., Malik, Y. S., & Singh, R. K. (2015) · International Journal of Pharmacology · doi:10.3923/ijp.2015.253.290 · Cited by 96
Complexities of targeting innate immunity to treat infection
Brown, K. L., Cosseau, C., Gardy, J. L., & Hancock, R. E. W. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.04.005 · Cited by 98
Self-citationAchtman, A. H., Pilat, S., Law, C. W., Lynn, D. J., Janot, L., Mayer, M. L., Ma, S., Kindrachuk, J., Finlay, B. B., Brinkman, F. S. L., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003515 · Cited by 94
Self-citationLo, H., Tang, C. M., & Exley, R. M. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70132-x · Cited by 97
Treatment of Oral Multispecies Biofilms by an Anti-Biofilm Peptide
Wang, Z., de la Fuente-Núñez, C., Shen, Y., Haapasalo, M., & Hancock, R. E. W. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132512 · Cited by 73
Self-citationTHE ROLE OF EPITHELIAL β -DEFENSINS AND CATHELICIDINS IN HOST DEFENSE OF THE LUNG
Hiemstra, P. S. (2007) · Experimental Lung Research · doi:10.1080/01902140701756687 · Cited by 93
Robinson, M. W., Alvarado, R., To, J., Hutchinson, A. T., Dowdell, S., Lund, M. E., Turnbull, L., Whitchurch, C. B., O’Brien, B. A., Dalton, J. P., et al. (2012) · The FASEB Journal · doi:10.1096/fj.12-213876 · Cited by 94
Novel anti-infectives: is host defence the answer?
Hamill, P., Brown, K. L., Jenssen, H., & Hancock, R. E. W. (2008) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2008.10.006 · Cited by 87
Self-citationThakur, A., Sharma, A., Alajangi, H. K., Jaiswal, P. K., Lim, Y., Singh, G., & Barnwal, R. P. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.07.103 · Cited by 86
Antiviral Potential of Cathelicidins
Barlow, P. G., Findlay, E. G., Currie, S. M., & Davidson, D. J. (2013) · Future Microbiology · doi:10.2217/fmb.13.135 · Cited by 89
Beaumont, P. E., McHugh, B. J., Findlay, E. G., Mackellar, A., Mackenzie, K. J., Gallo, R. L., Govan, J. R. W., Simpson, A. J., & Davidson, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099029 · Cited by 83
Odorranalectin Is a Small Peptide Lectin with Potential for Drug Delivery and Targeting
Li, J., Wu, H., Hong, J., Xu, X., Yang, H., Wu, B., Wang, Y., Zhu, J., Lai, R., Jiang, X., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002381 · Cited by 83
Podolnikova, N. P., Podolnikov, A. V., Haas, T. A., Lishko, V. K., & Ugarova, T. P. (2015) · Biochemistry · doi:10.1021/bi5013782 · Cited by 83
Sequestosome-1/p62 Is the Key Intracellular Target of Innate Defense Regulator Peptide
Yu, H. B., Kielczewska, A., Rozek, A., Takenaka, S., Li, Y., Thorson, L., Hancock, R. E. W., Guarna, M. M., North, J. R., Foster, L. J., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c109.073627 · Cited by 81
Self-citationBrown, K. L., Bylund, J., MacDonald, K. L., Song-Zhao, G. X., Elliott, M. R., Falsafi, R., Hancock, R. E. W., & Speert, D. P. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.06.005 · Cited by 81
Self-citationKindrachuk, J., Jenssen, H., Elliott, M. R., Townsend, R., Nijnik, A., Lee, S. F., Gerdts, V., Babiuk, L. A., Halperin, S. A., & Hancock, R. E. W. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.094 · Cited by 80
Self-citationPag, U., Oedenkoven, M., Sass, V., Shai, Y., Валерьевна, Ш. О., Antcheva, N., Tossi, A., & Sahl, H. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm479 · Cited by 79
Andreev, K., Bianchi, C., Laursen, J. S., Citterio, L., Hein-Kristensen, L., Gram, L., Kuzmenko, I., Olsen, C. A., & Gidalevitz, D. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.05.022 · Cited by 78
van Dijk, A. I. J. M., Molhoek, E. M., Veldhuizen, E. J. A., Bokhoven, J. L. M. T.-V., Wagendorp, E., Bikker, F. J., & Haagsman, H. P. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.05.019 · Cited by 78
van der Does, A. M., Bogaards, S. J. P., Ravensbergen, B., Beekhuizen, H., van Dissel, J. T., & Nibbering, P. H. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00652-09 · Cited by 78
Rescue of Dysfunctional Autophagy Attenuates Hyperinflammatory Responses from Cystic Fibrosis Cells
Mayer, M. L., Blohmke, C. J., Falsafi, R., Fjell, C. D., Madera, L., Turvey, S. E., & Hancock, R. E. W. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201404 · Cited by 77
Self-citation
Metadata
- Authors
- Scott, M. G., Dullaghan, E., Mookherjee, N., Glavas, N., Waldbrook, M., Thompson, A., Wang, A., Lee, K., Doria, S., Hamill, P., Yu, J. J., Li, Y., Donini, O., Guarna, M. M., Finlay, B. B., North, J. R., & Hancock, R. E. W.
- Affiliations
- City of Vancouver (CA)
- University of British Columbia (CA)
- Corresponding author
- Hancock, Robert E W
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2007-03-25
- Volume
- 25
- Issue
- 4
- Pages
- 465-472
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2040733257
- Cited by
- 403
- References
- 31
- Citations by year
- 2026: 16 · 2025: 12 · 2024: 19 · 2023: 15 · 2022: 14 · 2021: 20 · 2020: 16 · 2019: 15 · 2018: 22 · 2017: 16 · 2016: 25 · 2015: 28 · 2014: 14 · 2013: 30 · 2012: 29
- FWCI
- 25.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- monocytes, macrophages, methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, Salmonella typhimurium, Gram-positive pathogens, Gram-negative pathogens, inflammatory cytokines, MAPK signaling
- MeSH terms
- Animals, Anti-Infective Agents, Bacterial Infections, Disease Models, Animal, Gene Expression Regulation, Humans, Immunity, Innate, Inflammation, Lipopolysaccharides, Peptides, Treatment Outcome, Models, Immunological, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
